Tomohide Tsukahara Selected Research

Tomohide Tsukahara Research Topics

Disease

63	Neoplasms (Cancer) 06/2022 - 08/2004
16	Sarcoma (Soft Tissue Sarcoma) 02/2021 - 08/2005
14	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 01/2003
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2011
7	Neoplasm Metastasis (Metastasis) 05/2017 - 01/2013
6	Colonic Neoplasms (Colon Cancer) 01/2017 - 06/2011
6	Synovial Sarcoma (Synovioma) 09/2012 - 08/2002
5	Carcinoma (Carcinomatosis) 02/2021 - 10/2016
5	Testicular Neoplasms (Testicular Cancer) 01/2020 - 01/2016
4	Lung Neoplasms (Lung Cancer) 01/2017 - 02/2005
3	Renal Cell Carcinoma (Grawitz Tumor) 04/2022 - 10/2020
3	Carcinogenesis 01/2021 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2019 - 01/2013
2	Microsatellite Instability 01/2022 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 01/2017
2	Tuberculosis (Tuberculoses) 03/2021 - 01/2021
2	Adenocarcinoma of Lung 11/2020 - 01/2013
2	Adenocarcinoma 08/2019 - 01/2017
2	Hypoxia (Hypoxemia) 12/2016 - 05/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Melena 07/2021
1	Massive Hepatic Necrosis 06/2021
1	Granuloma 03/2021
1	Endometrial Neoplasms (Endometrial Cancer) 03/2021
1	Inflammation (Inflammations) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Cystitis 11/2020
1	Squamous Cell Carcinoma of Head and Neck 05/2020
1	Necrosis 02/2020
1	Alveolar Rhabdomyosarcoma 06/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Glioma (Gliomas) 01/2019
1	Nausea 10/2018
1	Headache (Headaches) 10/2018
1	Fatigue 10/2018
1	Kidney Neoplasms (Kidney Cancer) 03/2018

Drug/Important Bio-Agent (IBA)

33	AntigensIBA 04/2022 - 01/2003
32	Peptides (Polypeptides)IBA 04/2022 - 08/2002
10	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2016
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2007
8	HLA-A24 AntigenIBA 10/2020 - 08/2002
6	HLA Antigens (Human Leukocyte Antigens)IBA 05/2020 - 02/2008
6	SurvivinIBA 02/2020 - 06/2011
6	Protein Subunit VaccinesIBA 08/2019 - 02/2005
6	HLA-A Antigens (HLA-A)IBA 08/2014 - 12/2002
5	Messenger RNA (mRNA)IBA 01/2020 - 01/2009
5	EpitopesIBA 04/2019 - 06/2009
4	Oxidoreductases (Dehydrogenase)IBA 04/2017 - 05/2015
3	Aldehyde Dehydrogenase 1 FamilyIBA 01/2022 - 04/2017
3	incomplete Freund's adjuvantIBA 02/2020 - 06/2011
3	HLA-B55 antigenIBA 04/2019 - 06/2009
3	Histocompatibility Antigens Class IIBA 01/2017 - 05/2015
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 08/2014 - 02/2008
3	Cancer VaccinesIBA 01/2013 - 04/2009
2	Aldehyde DehydrogenaseIBA 01/2022 - 01/2016
2	LigandsIBA 11/2021 - 08/2019
2	NivolumabIBA 07/2021 - 06/2021
2	pembrolizumabIBA 07/2021 - 11/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2021 - 01/2019
2	Photosensitizing Agents (Photosensitizers)IBA 02/2021 - 01/2019
2	B7-H1 AntigenIBA 11/2020 - 04/2017
2	Single-Chain AntibodiesIBA 10/2020 - 08/2014
2	Gemcitabine FDA Link 08/2019 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 08/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 01/2016
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2018 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	Monoclonal AntibodiesIBA 08/2014 - 12/2006
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2014 - 02/2007
2	VaccinesIBA 09/2011 - 04/2009
2	Complementary DNA (cDNA)IBA 02/2007 - 08/2004
1	CTLA-4 AntigenIBA 04/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Long Noncoding RNAIBA 11/2021
1	IpilimumabIBA 06/2021
1	Talaporfin (talaporfin sodium)IBA 02/2021
1	Interleukin-13IBA 01/2021
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Interferon-alpha (Interferon Alfa)IBA 02/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2020
1	tegafur-gimeracil-oteracilIBA 08/2019
1	RNA (Ribonucleic Acid)IBA 06/2019
1	Drug CombinationsIBA 06/2019
1	Pharmaceutical PreparationsIBA 06/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	AcidsIBA 01/2019
1	protoporphyrin IXIBA 01/2019
1	TegafurIBA 10/2018
1	UracilIBA 10/2018
1	Immune Checkpoint ProteinsIBA 04/2017

Therapy/Procedure

35	Immunotherapy 06/2022 - 01/2003
24	Therapeutics 06/2021 - 02/2007
12	Drug Therapy (Chemotherapy) 01/2021 - 08/2004
6	Radiotherapy 01/2021 - 01/2013
2	Aftercare (After-Treatment) 03/2021 - 01/2013
1	Photochemotherapy (Photodynamic Therapy) 02/2021
1	Genomic Medicine 06/2019